Recent developments and highlights in allergen immunotherapy

Clinical trials in allergen immunotherapy: current concepts and future needs

(2018) O. Pfaar et al.   ALLERGY

Editorial: With tree nut sensitization, take the current when it serves, or lose our ventures

(2018) M. Greenhawt   ALLERGY

Perspectives in allergen immunotherapy: 2017 and beyond

(2018) O. Pfaar et al.   ALLERGY

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients

(2018) R. Mösges et al.   ALLERGY

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

(2018) M. Worm et al.   ALLERGY

Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

(2018) J. Bousquet et al.   ALLERGY

EAACI Position paper on the standardization of nasal allergen challenges

(2018) J. Augé et al.   ALLERGY

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

(2018) A. Bonertz et al.   ALLERGY

EAACI guidelines on allergen immunotherapy: Executive statement

(2018) A. Muraro et al.   ALLERGY

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial

(2018) R. Mösges et al.   ALLERGY

Treatment for food allergy

(2018) A. Wesley Burks et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

(2018) Verena Niederberger et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review

(2018) Jessica L. Rice et al.   PEDIATRICS

Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma

(2018) Ulrich Wahn et al.   ALLERGY

Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children

(2018) Keisuke Masuyama et al.   ALLERGY

Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: A Meta-analysis of Randomized Controlled Trials

(2018) Yanran Huang et al.   ALLERGY

A birch sublingual allergy immunotherapy (SLIT) tablet educes rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group

(2018) P Couroux et al.   ALLERGY

Intralymphatic Immunotherapy: Update and Unmet Needs

(2018) Gabriela Senti et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Allergen immunotherapy in allergic rhinitis: current use and future trends

(2017) Ludger Klimek et al.   Expert Review of Clinical Immunology

Clinical use of adjuvants in allergen-immunotherapy

(2017) Ludger Klimek et al.   Expert Review of Clinical Immunology

Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance

(2017) Margot Berings et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Diagnosis and management of anaphylaxis in precision medicine

(2017) Mariana Castells   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective

(2017) Brian P. Vickery et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment with grass allergen peptides improves symptoms of grass pollen–induced allergic rhinoconjunctivitis

(2017) Anne K. Ellis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

EAACI guidelines on allergen immunotherapy: Prevention of allergy

(2017) Susanne Halken et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States

(2017) Tolly G. Epstein et al.   Journal of Allergy and Clinical Immunology-In Practice

Sublingual Immunotherapy Dosing Regimens: What Is Ideal?

(2017) Jay J. Jin et al.   Journal of Allergy and Clinical Immunology-In Practice

Comparison of Pediatric and Adult Systemic Reactions to Subcutaneous Immunotherapy

(2017) Chen E. Lim et al.   Journal of Allergy and Clinical Immunology-In Practice

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis

(2016) Y. Okamoto et al.   ALLERGY

A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients

(2016) O. Pfaar et al.   ALLERGY

European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

(2016) M. A. Calderón et al.   ALLERGY

Allergen immunotherapy now and in the future

(2016) Harold S. Nelson   ALLERGY AND ASTHMA PROCEEDINGS

Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass

(2016) Andrzej Bozek et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy

(2016) Tolly G. Epstein et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Molecular Allergology between Precision Medicine and the Choosing Wisely initiative

(2016) P. M. Matricardi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Allergen immunotherapy for the polyallergic patient

(2016) Ulrich Wahn   Current Opinion in Allergy and Clinical Immunology

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma

(2016) J. Christian Virchow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy

(2016) Stacie M. Jones et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

(2016) François Spertini et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

(2016) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

(2016) Pascal Demoly et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

(2016) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review

(2016) Sangeeta Dhami et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis

(2016) Maria Kristiansen et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

EAACI Molecular Allergology User's Guide

(2016) P. M. Matricardi et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

(2016) Sangeeta Dhami et al.   Clinical and Translational Allergy

Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

(2016) Sangeeta Dhami et al.   Clinical and Translational Allergy

Allergen immunotherapy for allergic asthma: protocol for a systematic review

(2016) Sangeeta Dhami et al.   Clinical and Translational Allergy

Diagnostic test allergens used forin vivodiagnosis of allergic diseases are at risk: a European Perspective

(2015) L. Klimek et al.   ALLERGY

Clinical contraindications to allergen immunotherapy: an EAACI position paper

(2015) C. Pitsios et al.   ALLERGY

House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial

(2015) P. Devillier et al.   ALLERGY

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease

(2015) H. J. Hoffmann et al.   ALLERGY

Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens

(2015) J. Sastre et al.   ALLERGY

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study

(2015) O. Pfaar et al.   ALLERGY

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

(2015) J. Bousquet et al.   ALLERGY

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

(2015) G. Senti et al.   ALLERGY

SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

(2015) Holger Mosbech et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Administration of a probiotic with peanut oral immunotherapy: A randomized trial

(2015) Mimi L.K. Tang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International consensus on allergy immunotherapy

(2015) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

(2015) Margarete Focke-Tejkl et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy

(2015) Harold Nelson et al.   Journal of Allergy and Clinical Immunology-In Practice

Allergen immunotherapy for insect venom allergy: protocol for a systematic review

(2015) Sangeeta Dhami et al.   Clinical and Translational Allergy

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

(2015) Ludger Klimek et al.   Clinical and Translational Allergy

Allergen immunotherapy on the way to product-based evaluation—a WAO statement

(2015) Claus Bachert et al.   World Allergy Organization Journal

Intralymphatic immunotherapy

(2015) Gabriela Senti et al.   World Allergy Organization Journal

A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol

(2014) L. Klimek et al.   ALLERGY

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

(2014) O. Pfaar et al.   ALLERGY

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs

(2014) Ludger Klimek et al.   Expert Review of Clinical Immunology

Choosing Wisely — The Politics and Economics of Labeling Low-Value Services

(2014) Nancy E. Morden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Immunotherapy for Peanut Allergy: Multipractice Experience With Epinephrine-treated Reactions

(2014) Richard L. Wasserman et al.   Journal of Allergy and Clinical Immunology-In Practice

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

(2014) Giorgio Walter Canonica et al.   World Allergy Organization Journal

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

(2013) Jennifer Maloney et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

(2013) Terese Hylander et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Recombinant allergen-based provocation testing

(2013) Verena Niederberger et al.   METHODS

How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area

(2012) J. Sastre et al.   ALLERGY

Molecular Approaches to Allergen Standardization

(2012) Martin D. Chapman et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Adjuvants for immunotherapy

(2012) Oliver Pfaar et al.   Current Opinion in Allergy and Clinical Immunology

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

(2012) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Preparing for Precision Medicine

(2012) Reza Mirnezami et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvants for allergy vaccines

(2012) Philippe Moingeon   Human Vaccines & Immunotherapeutics

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile

(2011) M. A. Calderón et al.   ALLERGY

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

(2011) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study

(2010) Oliver Pfaar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Recombinant allergen-based IgE testing to distinguish bee and wasp allergy

(2010) Irene Mittermann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy

(2009) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual immunotherapy: Dosing in relation to clinical and immunological efficacy

(2008) Désirée E. Larenas-Linnemann   ALLERGY AND ASTHMA PROCEEDINGS

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

(2008) A. Purohit et al.   CLINICAL AND EXPERIMENTAL ALLERGY